National Bureau of Statistics: In the first three quarters of 2026, profits in the oral equipment manufacturing industry grew by 59.6%.

Source: National Bureau of Statistics

DentalGoodNews｜On October 27, 2026, the National Bureau of Statistics released industrial enterprise profit data for January-September 2026. Yu Weining, Chief Statistician of the Industrial Department of the National Bureau of Statistics, noted in his interpretation that the profit of the industry of Manufacture of Dental Equipment and Instruments increased by 59.6% year-on-year. During the same period, the profit of industrial enterprises above designated size nationwide increased by 15.5% year-on-year, and operating revenue increased by 6.6% year-on-year; the profit of high-tech manufacturing above designated size increased by 52.0% year-on-year.

Calculated on a comparable basis, the profit growth rate of the industry of Manufacture of Dental Equipment and Instruments was 44.1 percentage points higher than that of all industrial enterprises above designated size, and 7.6 percentage points higher than that of high-tech manufacturing as a whole.

According to previous reports by DGN, the industry's profit increased by 70.2% year-on-year in January-August 2026, and by 29.7% year-on-year for the full year of 2025. By comparison, the growth rate in January-September 2026 fell by 10.6 percentage points from January-August, and was 29.9 percentage points higher than the full year of 2025.

From the perspective of the national overall picture, the profit of industrial enterprises above designated size maintained double-digit growth throughout the year since the beginning of this year in January-September; in September alone, the profit of industrial enterprises above designated size increased by 14.4% year-on-year. By industry, the pharmaceutical manufacturing industry achieved total profit of 254.65 billion yuan in January-September, up 4.4% year-on-year; operating revenue was 1,741.69 billion yuan, down 0.2% year-on-year.

From the cost side, in January-September, the cost per 100 yuan of operating revenue of industrial enterprises above designated size was 85.02 yuan, down 0.45 yuan year-on-year; the operating revenue profit margin was 5.68%, up 0.44 percentage points year-on-year. During the same period, the operating cost of the pharmaceutical manufacturing industry was 1,000.18 billion yuan, up 0.5% year-on-year; based on the published operating revenue and operating cost, its cost per 100 yuan of operating revenue was approximately 57.43 yuan, and its operating revenue profit margin was approximately 14.62%.

The statistical scope covers industrial enterprises above designated size, i.e., industrial legal entities with annual main business revenue of 20 million yuan and above, and the growth rates of relevant indicators are calculated on a comparable basis.

Source: National Bureau of Statistics